- Matrix Metallopeptidase 3 Polymorphisms: Emerging genetic Markers in Human Breast Cancer Metastasis
-
Suhaimi SA, Chan SC, Rosli R
- KMID: 2470877
- J Breast Cancer.
- 2020 Feb;23(1):1-9.
- doi: 10.4048/jbc.2020.23.e17
Matrix metallopeptidase 3 or MMP3, is a zinc-dependent proteolytic enzyme that is involved in various physiological processes via modification of the extracellular matrix. In particular, its over-expression has been associated... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of the Prognostic Staging System of American Joint Committee on Cancer 8th Edition for Breast Cancer: Comparisons with the Conventional Anatomic Staging System
-
Kim EJ, Park HS, Kim JY, Kim SI, Cho YU, Park BW
- KMID: 2470882
- J Breast Cancer.
- 2020 Feb;23(1):59-68.
- doi: 10.4048/jbc.2020.23.e9
PURPOSE: The 8th edition of the American Joint Committee on Cancer (AJCC) staging manual introduced a new prognostic staging system for breast cancer. This study aimed to evaluate the changes... -
- CITED
-
- Close
- SHARE
-
- Close
- Erratum: A Validation Study of a Multiple Reaction Monitoring-Based Proteomic Assay to Diagnose Breast Cancer
-
Kim Y, Kang UB, Kim S, Lee HB, Moon HG, Han W, Noh DY
- KMID: 2470888
- J Breast Cancer.
- 2020 Feb;23(1):113-114.
- doi: 10.4048/jbc.2020.23.e6
In the article, “A Validation Study of a Multiple Reaction Monitoring-Based Proteomic Assay to Diagnose Breast Cancer†in Volume 22(4), page 579-586 was error in the table. In Table 1,... -
- CITED
-
- Close
- SHARE
-
- Close
- Acute Lymphoblastic Leukemia in a Patient Treated with Letrozole and Palbociclib
-
Park JH, Park H, Kim KH, Kim JS, Choi IS, Roh EY, Kim JE, Chang MS
- KMID: 2470886
- J Breast Cancer.
- 2020 Feb;23(1):100-106.
- doi: 10.4048/jbc.2020.23.e1
Palbociclib, in conjunction with endocrine therapy, has been approved for the treatment of patients with advanced breast cancer. The common hematological toxicities associated with palbociclib are leukopenia and neutropenia. However,... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of Robotic Mastectomy Using a Single-Port Surgical Robot System
-
Park HS, Lee J, Lee H, Lee K, Song SY, Toesca A
- KMID: 2470887
- J Breast Cancer.
- 2020 Feb;23(1):107-112.
- doi: 10.4048/jbc.2020.23.e3
Minimal invasive surgical technique has been increasingly applied to breast surgery. Since the first robot-assisted nipple-sparing mastectomy was introduced, we have been performing nipple-sparing mastectomy using multi-port robotic surgical system.... -
- CITED
-
- Close
- SHARE
-
- Close
- Malignant transformation in a Breast Adenomyoepithelioma Caused by Amplification of c-MYC: A Common pathway to Cancer in a Rare Entity
-
Febres-Aldana CA, Mejia-Mejia O, Krishnamurthy K, Mesko T, Poppiti R
- KMID: 2470885
- J Breast Cancer.
- 2020 Feb;23(1):93-99.
- doi: 10.4048/jbc.2020.23.e2
Breast adenomyoepitheliomas are composed of a biphasic proliferation of myoepithelial cells around small epithelial-lined spaces. Due to the rarity of adenomyoepitheliomas, the molecular data describing them are limited. Adenomyoepitheliomas are... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Tau Protein Expression in Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Different Molecular Subtypes of Breast Cancer
-
Lei C, Yang C, Xia B, Ji F, Zhang Y, Gao H, Xiong Q, Lin Y, Zhuang X, Zhang L, Zhu T, Cheng M, Yang M, Wang K
- KMID: 2470881
- J Breast Cancer.
- 2020 Feb;23(1):47-58.
- doi: 10.4048/jbc.2020.23.e11
PURPOSE: Tau is a microtubule-associated protein that can be found in both normal and abnormal breast cells. Whether the expression of Tau protein can predict the response to neoadjuvant chemotherapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Downregulation of N-myc and STAT Interactor Protein Predicts Aggressive Tumor Behavior and Poor Prognosis in Invasive Ductal Carcinoma
-
Choi JE, Hyun CL, Jin MS, Lee KM, Moon JH, Ryu HS
- KMID: 2470880
- J Breast Cancer.
- 2020 Feb;23(1):36-46.
- doi: 10.4048/jbc.2020.23.e12
PURPOSE: We investigated the expression of the N-myc and STAT interactor (NMI) protein in invasive ductal carcinoma tissue and estimated its clinicopathologic significance as a prognostic factor. The expression levels... -
- CITED
-
- Close
- SHARE
-
- Close
- Protocatechuic Aldehyde Represses Proliferation and Migration of Breast Cancer Cells through Targeting C-terminal Binding Protein 1
-
Deng Y, Guo W, Li G, Li S, Li H, Li X, Niu B, Song M, Zhang Y, Xu Z, Li F
- KMID: 2470879
- J Breast Cancer.
- 2020 Feb;23(1):20-35.
- doi: 10.4048/jbc.2020.23.e7
PURPOSE: C-terminal binding protein 1 (CtBP1) is a transcriptional co-repressor that is overexpressed in many cancers. CtBP1 transcriptionally represses a broad array of tumor suppressors, which promotes cancer cell proliferation,... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Value of Skeletal Muscle Depletion Measured on Computed Tomography for Overall Survival in Patients with Non-Metastatic Breast Cancer
-
Huh J, Park B, Lee H, An YS, Jung Y, Kim JY, Kang DK, Kim KW, Kim TH
- KMID: 2470884
- J Breast Cancer.
- 2020 Feb;23(1):80-92.
- doi: 10.4048/jbc.2020.23.e8
PURPOSE: The purpose of this study was to evaluate the prognostic value of skeletal muscle depletion measured on computed tomography (CT) in patients with non-metastatic invasive breast cancer. METHODS: This retrospective... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of Histo-blood Group Antigens in Tumor and Adjacent Normal Breast Tissues as Prognostic Markers of Breast Carcinoma
-
Zouine S, Marnissi F, Otmani N, Bennani Othmani M, Zaid N, Kojok K, Zaid Y, Tahiri Jouti N, Habti N
- KMID: 2470883
- J Breast Cancer.
- 2020 Feb;23(1):69-79.
- doi: 10.4048/jbc.2020.23.e13
PURPOSE: Aberrant glycosylation of the histo-blood group antigens (including the angina bullosa haemorrhagica [ABH]) is often observed during malignant transformation in most types of carcinomas. Data concerning their ethnic distributions... -
- CITED
-
- Close
- SHARE
-
- Close
- Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status
-
Choi J, Park CS, Seong MK, Seol H, Kim JS, Park IC, Noh WC, Kim HA
- KMID: 2470878
- J Breast Cancer.
- 2020 Feb;23(1):10-19.
- doi: 10.4048/jbc.2020.23.e5
PURPOSE: Phosphorylated ribosomal S6 kinase 1 (pS6K1) is a major downstream regulator of the mammalian target of rapamycin (mTOR) pathway. Recent studies have addressed the role of S6K1 in adipogenesis.... -
- CITED
-
- Close
- SHARE
-
- Close
